Assuntos: EPITOPOS, IMUNIDADE, MORBIDADE, VACINAÇÃO, SOBREVIDA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
V, C. Herst et al. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. Vaccine, v. 38, n. 28, p. 4464-4475, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2020.04.034. Acesso em: 21 ago. 2024.APA
V, C. H., Burkholz, S., Sidney, J., Sette, A., Harris, P. E., Massey, S., et al. (2020). An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. Vaccine, 38( 28), 4464-4475. doi:10.1016/j.vaccine.2020.04.034NLM
V CH, Burkholz S, Sidney J, Sette A, Harris PE, Massey S, Brasel T, Cunha Neto E, Rosa DS, Chao WCH. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design [Internet]. Vaccine. 2020 ; 38( 28): 4464-4475.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.vaccine.2020.04.034Vancouver
V CH, Burkholz S, Sidney J, Sette A, Harris PE, Massey S, Brasel T, Cunha Neto E, Rosa DS, Chao WCH. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design [Internet]. Vaccine. 2020 ; 38( 28): 4464-4475.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.vaccine.2020.04.034